Here, we successfully identified the glycolytic metabolic profile of PKM2 in kidney cancer cells and found that PKM2 inhibition not only suppressed 786-O cell energy metabolism (glycolysis) but also inhibited kidney cancer cell proliferation, survival, migration, and invasion. This evidence concerns the gene PKM and kidney cancer.